These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5871247)

  • 1. Bacterial clearance in patients with lepromatous leprosy not receiving treatment.
    Browne SG
    Lepr Rev; 1965 Oct; 36(4):161-2. PubMed ID: 5871247
    [No Abstract]   [Full Text] [Related]  

  • 2. Dapsone toxicity.
    Verma KC; Singh K; Chowdhary SD
    J Indian Med Assoc; 1973 Apr; 60(7):255. PubMed ID: 4732625
    [No Abstract]   [Full Text] [Related]  

  • 3. Dapsone induced psychosis--a case report.
    Sahu DM
    Indian J Dermatol; 1972 Jan; 17(2):47-8. PubMed ID: 5039891
    [No Abstract]   [Full Text] [Related]  

  • 4. Antileprosy drugs.
    Jopling WH
    Br Med J; 1971 Nov; 4(5783):366. PubMed ID: 5124426
    [No Abstract]   [Full Text] [Related]  

  • 5. Antileprosy drugs.
    Browne SG
    Br Med J; 1971 Nov; 4(5786):558-9. PubMed ID: 5128221
    [No Abstract]   [Full Text] [Related]  

  • 6. Dapsone induced psychosis.
    Balkrishna ; Bhatia MS
    J Indian Med Assoc; 1989 May; 87(5):120-1. PubMed ID: 2600436
    [No Abstract]   [Full Text] [Related]  

  • 7. The neurotoxicity of dapsone.
    Daneshmend TK
    Adverse Drug React Acute Poisoning Rev; 1984; 3(1):43-58. PubMed ID: 6091422
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of lepromatous leprosy by ethionamide].
    Rollier R; Rollier M
    Maroc Med; 1972 Mar; 52(555):148-66. PubMed ID: 4261347
    [No Abstract]   [Full Text] [Related]  

  • 9. Dapsone-induced psychosis.
    Bhatia MS; Singhal PK; Balkrishna ; Dhar NK
    Indian J Pediatr; 1988; 55(1):153-4. PubMed ID: 3378843
    [No Abstract]   [Full Text] [Related]  

  • 10. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy.
    Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive episodes in borderline lepromatous leprosy--a case report.
    Acharya PV; Gupta OP; Nigam SP; Agrawal RV
    Lepr India; 1976 Jul; 48(3):311-3. PubMed ID: 1022972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations into the haemolytic effects of dapsone therapy in leprosy patients.
    Balakrishnan S; Karthikeyan S; Ramu G
    Indian J Lepr; 1989 Jan; 61(1):10-6. PubMed ID: 2703739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal reaction to dapsone during treatment of leprosy.
    Frey HM; Gershon AA; Borkowsky W; Bullock WE
    Ann Intern Med; 1981 Jun; 94(6):777-9. PubMed ID: 7235421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antileprosy drugs.
    Garrett AS
    Br Med J; 1971 Oct; 4(5782):300. PubMed ID: 5123920
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined clofazimine- and dapsone-resistant leprosy. A case report.
    Kar HK; Bhatia VN; Harikrishnan S
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapsone induced hypohaptoglobinemia in lepromatous leprosy patients.
    Sritharan V; Bharadwaj VP; Venkatesan K; Girdhar BK
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):307-10. PubMed ID: 7198620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapsone induced pulmonary eosinophilia without cutaneous allergic manifestations--an unusual encounter--a case report.
    Arunthathi S; Raju S
    Acta Leprol; 1998; 11(1):3-5. PubMed ID: 9693685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effects of dapsone.
    Graham WR
    Int J Dermatol; 1975 Sep; 14(7):494-500. PubMed ID: 1099035
    [No Abstract]   [Full Text] [Related]  

  • 20. Ten years of dapsone in lepromatous leprosy: clinical, bacteriological and histological assessment and the finding of viable leprosy bacilli.
    Waters MF; Rees RJ; McDougall AC; Weddell AG
    Lepr Rev; 1974 Dec; 45(4):288-98. PubMed ID: 4613977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.